Development of historic deacetylase inhibitors.

被引：0
|
作者：
Richon, VM [1 ]
机构：
[1] Aton Pharma Inc, Tarrytown, NY USA
来源：
CLINICAL CANCER RESEARCH | 2003年 / 9卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：6272S / 6272S
页数：1
相关论文
共 50 条
  • [31] Historic deacetylase inhibitors for epigenetic therapy of cancer (vol 18, pg 363, 2007)
    Monneret
    ANTI-CANCER DRUGS, 2007, 18 (05) : 619 - 619
  • [32] Angiogenesis inhibitors.
    Tennant T.R.
    Rinker-Schaeffer C.W.
    Stadler W.M.
    Current Oncology Reports, 2000, 2 (1) : 11 - 16
  • [33] Historic deacetylase inhibitors as mediators of antiinflammatory and anti-proliferative effects in experimental colitis
    不详
    IMMUNOBIOLOGY, 2005, 210 (6-8) : 599 - 599
  • [34] Silanediol metalloprotease inhibitors. Synthesis and evaluation of four ace inhibitors.
    Kim, J
    Hewitt, GW
    Mutahi, MW
    Nittoli, T
    Guo, LX
    Sieburth, SM
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 225 : U205 - U205
  • [35] A work in progress - The clinical development of histone deacetylase inhibitors
    Marsoni, Silvia
    Damia, Giovanna
    Camboni, Gabriella
    EPIGENETICS, 2008, 3 (03) : 164 - 173
  • [36] Histone deacetylase inhibitors: discovery and development as anticancer agents
    Marks, PA
    Dokmanovic, M
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2005, 14 (12) : 1497 - 1511
  • [37] Search for novel histone deacetylase inhibitors. Part II: Design and synthesis of novel isoferulic acid derivatives
    Lu, Wen
    Wang, Fang
    Zhang, Tao
    Dong, Jinyun
    Gao, Hongping
    Su, Ping
    Shi, Yaling
    Zhang, Jie
    BIOORGANIC & MEDICINAL CHEMISTRY, 2014, 22 (09) : 2707 - 2713
  • [38] Clinical and mechanistic development of histone deacetylase (HDAC) inhibitors
    Wright, John
    Bates, Susan
    Piekarz, Richard
    ANNALS OF ONCOLOGY, 2008, 19 : 23 - 23
  • [39] Development of histone deacetylase inhibitors as therapeutics for neurological disease
    Gottesfeld, Joel M.
    Pandolfo, Massimo
    FUTURE NEUROLOGY, 2009, 4 (06) : 775 - 784
  • [40] Clinical development of histone deacetylase inhibitors as anticancer agents
    Drummond, DC
    Noble, CO
    Kirpotin, DB
    Guo, ZX
    Scott, GK
    Benz, CC
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2005, 45 : 495 - 528
12345